Invention Grant
- Patent Title: Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis
-
Application No.: US16609878Application Date: 2018-05-03
-
Publication No.: US11427646B2Publication Date: 2022-08-30
- Inventor: Armelle Cuvillier , Gaël Champier
- Applicant: B Cell Design
- Applicant Address: FR Limoges
- Assignee: B Cell Design
- Current Assignee: B Cell Design
- Current Assignee Address: FR Limoges
- Agency: Morgan, Lewis & Bockius LLP
- Priority: EP17305498 20170504
- International Application: PCT/EP2018/061385 WO 20180503
- International Announcement: WO2018/202794 WO 20181108
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61P35/00 ; A61K45/06
Abstract:
The invention relates to antibodies against carcinoembryonic antigen (CEA) which have a direct cell growth inhibition activity on tumor cells expressing CEA and to their use for the treatment and diagnosis of cancer.
Public/Granted literature
- US20200055952A1 Antibodies Against Carcinoembryonic Antigen for Cancer Therapy and Diagnosis Public/Granted day:2020-02-20
Information query
